Browse by author
Lookup NU author(s): Dr Mary Slatter,
Professor Andrew GenneryORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The transplantation of hematopoietic stem cells in patients with primary immunodeficiencies has improved significantly over the last 40 years. In favorable circumstances when there is minimal or no infection present, no end-organ damage and the availability of a well HLA-matched donor, survival and cure reaches 90%. Barriers to further success include late identification of disease, with accumulation of infection- and inflammation-related organ damage, stem cell manipulation when there is no HLA-matched donor, toxicity of conditioning regimens and prediction and treatment of graft-versus-host disease. This review will outline recent developments in conditioning regimens, stem cell source manipulation and early detection and treatment of graft-versus-host disease, with a particular emphasis on patients with primary immunodeficiency.
Author(s): Slatter MA, Gennery AR
Publication type: Review
Publication status: Published
Journal: Expert Review of Clinical Immunology
Print publication date: 01/10/2013
ISSN (print): 1744-666X
ISSN (electronic): 1744-8409
Publisher: EXPERT REVIEWS